文献速递头颈外科耳科与耳神经

大分割机器人立体定向放射外科治疗迷走神经副神经节瘤:保留脑神经的新策略

Hypofractionated Robotic Stereotactic Radiosurgery for Vagal Paragangliomas: A Novel Treatment Strategy for Cranial Nerve Preservation.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-03-03

该回顾性研究首次描述了大分割立体定向放射外科(SRS)治疗迷走神经副神经节瘤(VPs)的肿瘤控制与安全性,纳入4例男性患者的5个VPs。所有肿瘤在末次随访时稳定或缩小,且多数患者迷走神经功能正常,治疗相关副作用自限。SRS可作为保留脑神经的治疗选择,尤其适用于对侧下组脑神经缺损或多发副神经节瘤风险者。

要点

  • 大分割SRS对VPs的肿瘤控制良好,末次随访均稳定或缩小。
  • 多数患者治疗后迷走神经功能正常,治疗相关副作用自限。
  • SRS可考虑作为保留脑神经的治疗选项。

核心结论

  • 大分割SRS对VPs安全有效,包括大体积和 predominantly 颅外肿瘤,并能保留迷走神经功能。

研究设计与样本

  • 回顾性病历 review,纳入4例男性患者的5个VPs,年龄15-56岁,2010-2018年接受SRS。

主要发现

  • 所有肿瘤末次随访(63-85个月,平均76个月)稳定(n=3)或缩小(n=2)。
  • 1例患者因既往同侧颈静脉球瘤切除术存在稳定的病前声带麻痹,其余患者SRS后迷走神经功能正常。
  • 治疗相关副作用包括味觉障碍(n=1)、黏膜炎(n=1)和颈部软组织水肿(n=2),均自限。

关键数值与推荐

  • 处方剂量24或27 Gy(最大剂量33.4 Gy;范围29.3-35.5 Gy),分3次等分照射。
  • 平均等剂量线79%(范围76%-82%)。
  • 治疗体积范围8.81-86.3 cm3(平均35.7 cm3)。

临床怎么用

  • SRS应被视为保留脑神经的选项,尤其在对侧下组脑神经缺损或多发副神经节瘤风险双侧迷走神经时。

局限性

  • 回顾性设计,样本量小(4例患者5个肿瘤),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To provide the first description of hypofractionated stereotactic radiosurgery (SRS) and evaluate tumor control and safety for vagal paragangliomas (VPs), which begin at the skull base but often have significant extracranial extension. STUDY DESIGN: Retrospective chart review. SETTING: Tertiary-referral neurotology and neurosurgery practice. SUBJECTS AND METHODS: Five VPs in 4 patients (all male, ages 15-56 years) underwent SRS between 2010 and 2018. Outcome measures included tumor dimensions on serial imaging, cranial nerve function, and radiation side effects. RESULTS: CyberKnife hypofractionated SRS was performed. The prescription dose was 24 or 27 Gy (maximum dose 33.4 Gy; range, 29.3-35.5 Gy) delivered in 3 equal fractions. The mean isodose line was 79% (range, 76%-82%). Four VPs were treated primarily, and 1 tumor underwent SRS to treat regrowth 2 years after microsurgical subtotal resection via the modified infratemporal fossa approach. The treatment volume ranged from 8.81 to 86.3 cm3 (mean, 35.7 cm3). All demonstrated stable size (n = 3) or regression (n = 2) at last follow-up, 63 to 85 months after SRS (mean, 76 months). One patient had stable premorbid vocal fold paralysis from a prior ipsilateral glomus jugulare tumor resection. All others demonstrated normal vagal function following SRS. Treatment-related side effects, including dysgeusia (n = 1), mucositis (n = 1), and neck soft-tissue edema (n = 2), were self-limited. CONCLUSIONS: Hypofractionated SRS appears to be both safe and effective for treating VPs, including large-volume and predominantly extracranial tumors, while preserving vagal function. SRS should be considered as a cranial nerve preservation option, especially in settings of contralateral lower cranial nerve deficits or in those with multiple paragangliomas risking both vagal nerves.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Maxwell AK, Mehta GU, Muelleman T, et al. Hypofractionated Robotic Stereotactic Radiosurgery for Vagal Paragangliomas: A Novel Treatment Strategy for Cranial Nerve Preservation. Otolaryngol Head Neck Surg. 2020. PMID: 32125943. doi:10.1177/0194599820910150

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。